A Review of Factors Associated with Age of First Injection.


Journal

Journal of psychoactive drugs
ISSN: 2159-9777
Titre abrégé: J Psychoactive Drugs
Pays: United States
ID NLM: 8113536

Informations de publication

Date de publication:
Historique:
pubmed: 17 8 2020
medline: 31 8 2021
entrez: 16 8 2020
Statut: ppublish

Résumé

Injection drug use (IDU) is of increasing public health concern in the United States. Misuse of and addiction to opioids has contributed to declining life expectancies and rebounding risk of HIV and HCV acquisition among people who inject drugs. While some effective treatment strategies for individuals with substance use disorders have been established, effective interventions to prevent IDU require greater tailoring to subpopulations and social contexts. To better understand contextual variables associated with initiation of IDU, we conducted a narrative review of the existing literature that assessed correlates of age of first injection. We found sixteen studies that met our inclusion criteria. Across studies, later IDU initiation was associated with being African American and female, while early initiation was associated with earlier illicit substance use, childhood trauma, and incarceration. We also found that early initiation was associated with riskier substance-using behaviors, though the findings were mixed with respect to differences between early and late initiates in infectious disease prevalence. These correlates of age of first injection can potentially inform tailored injection prevention strategies. By identifying the features and behaviors of relevant subpopulations before they inject, interventions to prevent IDU could become more effective.

Identifiants

pubmed: 32795151
doi: 10.1080/02791072.2020.1804648
pmc: PMC7704573
mid: NIHMS1621711
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

412-420

Subventions

Organisme : NIDA NIH HHS
ID : K23 DA043418
Pays : United States

Références

J Adolesc Health. 2006 Apr;38(4):462-4
pubmed: 16549314
Sex Transm Infect. 2010 Dec;86 Suppl 3:iii79-84
pubmed: 21098060
Lancet. 2008 Nov 15;372(9651):1733-45
pubmed: 18817968
MMWR Morb Mortal Wkly Rep. 2019 May 03;68(17):388-395
pubmed: 31048676
J Public Health (Oxf). 2010 Sep;32(3):336-41
pubmed: 20421237
Subst Use Misuse. 2014 Aug;49(10):1311-6
pubmed: 24708431
Public Health Rep. 2001;116 Suppl 1:136-45
pubmed: 11889281
MMWR Morb Mortal Wkly Rep. 2015 May 1;64(16):443-4
pubmed: 25928470
Drug Alcohol Depend. 2014 May 1;138:244-50
pubmed: 24661392
AIDS Care. 2009 Aug;21(8):984-91
pubmed: 20024754
Drug Alcohol Depend. 2005 Mar 7;77(3):303-9
pubmed: 15734230
MMWR Morb Mortal Wkly Rep. 2018 Mar 02;67(8):257-258
pubmed: 29494569
Subst Use Misuse. 2017 May 12;52(6):754-759
pubmed: 28157414
Drug Alcohol Depend. 2017 Jun 1;175:210-218
pubmed: 28448905
J Viral Hepat. 2014 Jan;21(1):25-32
pubmed: 24329854
Annu Rev Public Health. 2015 Mar 18;36:559-74
pubmed: 25581144
J Urban Health. 2018 Feb;95(1):91-98
pubmed: 28948444
Am J Public Health. 2005 Apr;95(4):689-95
pubmed: 15798131
Drug Alcohol Depend. 2018 Apr 1;185:253-259
pubmed: 29477084
MMWR Morb Mortal Wkly Rep. 2018 Jan 04;67(5152):1419-1427
pubmed: 30605448
Int J Drug Policy. 2007 Oct;18(5):352-8
pubmed: 17854722
Drug Alcohol Rev. 2017 Sep;36(5):639-642
pubmed: 28334473
Addiction. 1996 Aug;91(8):1187-96
pubmed: 8828246
Drug Alcohol Depend. 2013 Dec 1;133(2):669-76
pubmed: 24055187
J Infect Dis. 2019 Jul 2;220(3):346-349
pubmed: 30941402
Drug Alcohol Depend. 2014 Apr 1;137:48-54
pubmed: 24529687
MMWR Morb Mortal Wkly Rep. 2019 Mar 15;68(10):253-254
pubmed: 30870405
J Subst Abuse Treat. 2015 Jan;48(1):13-20
pubmed: 25124258
Am J Public Health. 2005 Apr;95(4):703-9
pubmed: 15798133
MMWR Morb Mortal Wkly Rep. 2019 Apr 19;68(15):344-349
pubmed: 30998671
Addiction. 2006 Apr;101(4):548-55
pubmed: 16548934
Am J Public Health. 2016 Feb;106(2):298-300
pubmed: 26691120
Int J Infect Dis. 2006 Sep;10(5):364-71
pubmed: 16793307
AIDS Behav. 2019 Sep;23(9):2304-2314
pubmed: 30879209

Auteurs

Matthew McLaughlin (M)

Behavioral Medicine Program, Department of Psychiatry, Massachusetts General Hospital , Boston, MA, USA.

Andres Amaya (A)

The Fenway Institute, Fenway Health , Boston, MA, USA.

Monina Klevens (M)

Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health , Boston, MA, USA.

Conall O'Cleirigh (C)

Behavioral Medicine Program, Department of Psychiatry, Massachusetts General Hospital , Boston, MA, USA.
The Fenway Institute, Fenway Health , Boston, MA, USA.
Harvard Medical School, Harvard University , Boston, MA, USA.

Abigail Batchelder (A)

Behavioral Medicine Program, Department of Psychiatry, Massachusetts General Hospital , Boston, MA, USA.
The Fenway Institute, Fenway Health , Boston, MA, USA.
Harvard Medical School, Harvard University , Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH